Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

UFS Business School positioned as key partner in the fight against fraud
2016-11-21

A collaborative effort to curb the scourge of fraud in public and private companies has been identified as the most effective method at the launch of International Fraud Awareness week, 13-19 November.  The programme kicked off with a media briefing held in Bloemfontein, under the theme: “Curb Fraud and Accelerate Economic Transformation”.  At this occasion, the Free State Provincial Treasury and key partner institutions which are: UFS Business School, Standard Bank, Association of Certified Fraud Examiners (ACFE), and PricewaterhouseCoopers, made a pronouncement on their efforts to stop fraud in public and private institutions.

Strategic partnerships empower companies
The UFS Business School, in collaboration with Strategic Investigations and Seminars, formed a collaborative effort to present the Advanced Certificate in Fraud Examination, thus empowering individual companies to have within their ranks, certified fraud examiners.  The programme is a registered SAQA, NQF level 7 course comprising four modules; Law, Investigation, Fraud Prevention, Detection and Ethics, Financial Transactions and Fraud Schemes. Students are assisted to continue to the ACFE Board examination in order to become internationally accredited. In 2016, a new e-learning model was introduced to decrease the time spent away from the workplace, thereby encouraging more professionals to enrol.

Commitment is key driving force

Speaking at the media briefing, Jo’Anni Deacon, Senior Officer at the UFS Business School, said “by presenting the programme, the university had positioned itself as a key partner with provincial government and other entities in the fight against fraud”.

Head of Department in the Free State Provincial Treasury, Godfrey Mahlatsi, reiterated the stance of zero tolerance against fraud, and that the department was committed to ensuring that this partnership continued to grow, enabling all to strengthen the message that fraud and corruption undermined the goals and objectives of the National Development Plan.

Gerhard Geldenhuys, Director of PwC Forensic Services said: “I believe we are making a difference and further believe that the time for dialogue on fraud is now better than ever.”

The week-long campaign encourages employees (both in the public and private sector), and business leaders, to proactively take action to minimise the impact of fraud in their environments.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept